Aligned Genetics, Inc. (KOSDAQ: 238120)

Aligned Genetics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	14,959	14,927	10,696	6,137	5,639	4,898
Short-Term Investments	-	-	3,000	7,000	6,500	9,001
Cash & Short-Term Investments	14,959	14,927	13,696	13,137	12,139	13,899
Cash Growth	7.01%	8.99%	4.25%	8.22%	-12.66%	0.33%
Accounts Receivable	1,817	2,667	1,451	2,130	1,274	984.04
Other Receivables	132.81	55.64	17.55	293.91	219.34	174.84
Receivables	1,949	2,723	1,469	2,424	1,494	1,159
Inventory	4,686	3,852	3,759	2,353	2,110	2,120
Prepaid Expenses	86.42	13.01	343.11	58.1	70.99	79.16
Other Current Assets	153.02	88.1	284.98	413.05	128.57	37.39
Total Current Assets	21,833	21,603	19,552	18,386	15,942	17,294
Property, Plant & Equipment	7,833	8,035	7,285	5,776	1,673	2,039
Long-Term Investments	8,497	8,584	7,233	7,744	6,986	4,321
Other Intangible Assets	52.29	31.03	64.35	101.08	152.42	208.49
Long-Term Deferred Tax Assets	1,756	2,064	2,043	1,780	-	-
Long-Term Deferred Charges	-	-	-	0	71.52	166.2
Other Long-Term Assets	846.01	615.37	723.89	683.35	656.94	590.61
Total Assets	41,199	40,932	36,901	34,469	25,481	24,619
Accounts Payable	120.1	164.9	134.26	144.46	278.44	157.4
Accrued Expenses	41.26	130.05	277.79	150.37	143.95	138.57
Current Portion of Long-Term Debt	-	3,900	-	-	-	-
Current Portion of Leases	175.47	175.47	235.32	214.76	211.59	286.43
Current Income Taxes Payable	37.98	77.4	87.32	-	-	-
Current Unearned Revenue	-	9.86	-	-	-	-
Other Current Liabilities	841.49	780.35	598.52	907.73	585.46	318.84
Total Current Liabilities	1,216	5,238	1,333	1,417	1,219	901.23
Long-Term Debt	2,400	-	3,900	3,900	-	-
Long-Term Leases	438.79	587.61	243.97	320.97	916.77	994.02
Other Long-Term Liabilities	351.11	284.31	152.49	98.52	270.52	349.39
Total Liabilities	8,207	9,620	8,052	7,477	4,017	3,653
Common Stock	7,189	7,189	3,595	3,595	3,595	1,797
Additional Paid-In Capital	22,646	22,646	26,259	26,259	26,259	28,056
Retained Earnings	3,435	1,680	-1,202	-2,936	-8,449	-8,903
Comprehensive Income & Other	-278.68	-203.85	197.9	74.85	59.14	16.23
Shareholders' Equity	32,992	31,311	28,850	26,992	21,464	20,967
Total Liabilities & Equity	41,199	40,932	36,901	34,469	25,481	24,619
Total Debt	3,014	4,663	4,379	4,436	1,128	1,280
Net Cash (Debt)	11,945	10,264	9,317	8,701	11,010	12,619
Net Cash Growth	22.53%	10.17%	7.07%	-20.97%	-12.74%	-8.91%
Net Cash Per Share	604.39	713.81	647.93	605.15	1058.68	877.57
Filing Date Shares Outstanding	14.38	14.38	14.38	14.38	14.38	14.38
Total Common Shares Outstanding	14.38	14.38	14.38	14.38	14.38	14.38
Working Capital	20,617	16,365	18,219	16,968	14,722	16,393
Book Value Per Share	2294.44	2177.60	2006.39	1877.21	1492.72	1458.14
Tangible Book Value	32,939	31,280	28,785	26,891	21,311	20,758
Tangible Book Value Per Share	2290.81	2175.44	2001.92	1870.18	1482.12	1443.64
Land	1,557	-	-	1,557	-	-
Buildings	2,974	-	-	2,974	-	-
Machinery	2,726	-	-	2,001	1,780	1,664

Source: S&P Capital IQ. Standard template. Financial Sources.